市場調査レポート
商品コード
1389614

経皮ドラッグデリバリーシステム市場規模・予測、世界・地域別シェア、動向、成長機会分析レポート対象範囲:タイプ別、用途別、流通チャネル別

Transdermal Drug Delivery System Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel

出版日: | 発行: The Insight Partners | ページ情報: 英文 233 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.45円
経皮ドラッグデリバリーシステム市場規模・予測、世界・地域別シェア、動向、成長機会分析レポート対象範囲:タイプ別、用途別、流通チャネル別
出版日: 2023年10月23日
発行: The Insight Partners
ページ情報: 英文 233 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮ドラッグデリバリーシステムの世界市場は、2022年の372億3,000万米ドルから2030年には519億4,900万米ドルに達すると予測されます。2022年から2030年までのCAGRは4.3%と推定されます。

市場の成長を促す主な要因としては、経皮ドラッグデリバリーシステムの応用分野の拡大、脊髄損傷患者の増加などが挙げられます。しかし、術後の合併症が市場成長の妨げとなっています。

経皮ドラッグデリバリーシステムの市場機会

経皮ドラッグデリバリーシステムは、新規かつ信頼性の高い持続的ドラッグデリバリー手段の一つです。この分野で重要な研究が行われ、この形態のドラッグデリバリーに対する研究者の関心が高まっていることから、今後、多くの経皮パッチがマーケットプレースに登場する可能性が高いです。経皮パッチは、ニコチン、フェンタニル、ニトログリセリン、クロニジンなどの薬物を送達し、さまざまな病状を治療するために使用されます。最近では、これらのパッチは、様々な用途で生物製剤を送達するために研究されています。スマート・パッチは、患者の状態をモニターし、それに応じてドラッグデリバリーを調整するためのセンサーやその他の技術を備えています。2023年1月、スウォンジー大学の主任科学者は、マイクロニードル技術を用いてパーキンソン病やアルツハイマー病などの神経変性疾患の炎症性バイオマーカーを検出する新しいスマートパッチを開発しました。このスマートパッチは、低侵襲で皮膚バリアを貫通するように設計された多数のマイクロニードルで構成され、その後、臨床的に重要なバイオマーカーをモニタリングします。一般診療所や自宅でのポイントオブケア診断のために自己投与することができます。この革新的な調査によって、神経変性疾患の早期発見が大きく変わる可能性があります。

皮膚外用3Dプリント製品:2021年11月にNational Library of Medicineに掲載された「From Personalized Dressings to Drug Delivery」によると、皮膚表面に適合するパーソナライズされた3Dプリントパッチは、アセチルヘキサペプチド3(AHP-3)のデリバリーに使用できます。この研究では、ポリエチレングリコールジアクリレート(PEGDA)とビニルピロリドン(VP)という2種類の液体モノマーを異なる割合で使用し、最終ポリマーの機械的強度、重合速度、膨潤速度を改善しました。樹脂への最適な薬物担持により、AHP-3は製造工程を通じて安定であり、最終ポリマーの物性に影響を及ぼさないことが示されました。3Dスキャンされた顔面モデルを用いて、パーソナライズされたパッチがコンピュータ支援設計ソフトウェアで設計され、デジタル光加工3Dプリンタを用いて最適化された樹脂で作製されました。調製された経皮パッチのin-vitro特性評価により、ヒトの死体皮膚に浸透する能力が示され、さらに圧縮しても無傷のままであることが確認されました。「皮膚外用3Dプリント製品:パーソナライズド・ドレッシングからドラッグデリバリーまで"は、フォトポリマーを用いてパーソナライズド・パッチを実証した最初の研究であり、効果的なシワ管理のための薬剤の経皮デリバリーを改善する新しいアプローチを紹介しました。

このように、3Dプリンティング技術とスマートパッチの採用は、今後数年間、経皮ドラッグデリバリーシステム市場に機会を提供する可能性が高いです。

経皮ドラッグデリバリーシステム市場を阻害する要因

現在販売されている経皮ドラッグデリバリーシステム(TDDS)、経粘膜ドラッグデリバリーシステム(TMDS)、局所用パッチは、意図した使用期間終了後、最初の薬剤総量の10~95%が残留薬剤として残る可能性があります。このことは、患者やその家族、介護者にとって潜在的な安全性の問題を引き起こします。例えば、患者が意図した使用期間の終了時にTDDSを除去しなかったことによる有害事象は、一般に薬物の薬理作用の増大または延長をもたらします。また、廃棄されたTDDSに誤って曝露して死亡した小児も報告されています。以下は、メーカーによる製品の回収・撤回の一部です。

2023年2月、 Aveva Drug Delivery Systems Incは、ブプレノルフィン経皮吸収システムの2ロットを、不純物/分解仕様を満たしていないとして回収しました。Aveva Drug Delivery Systems社は2023年2月15日に自主的にリコールを開始し、2023年3月14日にFDAによりクラスIIIリコールに指定されました。このリコール分類では、製品の使用が重大な危害を引き起こす可能性はないとされています。2020年9月、Teva Pharmaceuticals USA社は2ロットのブプレノルフィンパッチをリコールしました。リコールの対象となったのは、ロット 190017および190161のブプレノルフィン経皮吸収システム(パッチNDC 0093-3656-21、カートンNDC 0093-3656-40)1カートンあたり4枚、1時間あたり5 mcg、32,543カートンです。この製品は3Mドラッグデリバリーシステムズがテバ・ファーマシューティカルズのために製造し、米国およびプエルトリコで販売されていました。Teva Pharmaceuticals社による2020年9月4日の自主回収に続き、FDAは2020年10月1日にリコールをクラスⅡに指定しました。クラスⅡのリコール製品の使用を継続すると、一時的または医学的に可逆的な健康上の悪影響が生じる可能性があります。遠隔ではあるが、重大な危害の可能性が存在します。さらに2018年4月、FDAはPhase 4 Pharmaceutical LLCに警告書を送付しました。同社は経皮吸収型製剤を製造する代わりに、一般用医薬品(OTC)経皮吸収型製剤の再包装業者として機能しており、FDAは製品の品質に影響を及ぼす複数のCGMP違反を発見しました。2019年4月、Alvogen, Inc.は、ラベルの取り違えを理由に、フェンタニル経皮システム、12 mcg/h経皮パッチの2ロット(またはバッチ)の全国自主回収を発表しました。このように、経皮ドラッグデリバリーシステムの副作用やリコールは市場成長の妨げとなっています。

経皮ドラッグデリバリーシステム市場:セグメント別概要

経皮ドラッグデリバリーシステム市場は、製品別に経皮パッチ、経皮ゲル、経皮スプレー、その他に区分されます。経皮パッチセグメントはさらに、薬物接着パッチ、リザーバー膜パッチ、マトリックスパッチ、蒸気パッチに区分されます。経皮パッチセグメントは2022年に市場で最大のシェアを占め、経皮ゲルは2022-2030年に最も高いCAGRを記録すると予測されています。経皮パッチは、患者の皮膚に貼り付けて皮膚から薬剤を送達するドラッグデリバリーシステムです。

経皮ドラッグデリバリーシステム市場は、用途別に心血管疾患、中枢神経障害、ホルモン用途、疼痛管理、その他の用途に区分されています。疼痛管理分野は、オピオイド用途と非オピオイド用途に細分化されています。ホルモン用途市場は、さらに経皮エストロゲン療法とテストステロン補充療法に区分されます。疼痛管理セグメントは2022年に市場で最大のシェアを占めました。中枢神経系疾患セグメントは、2022~2030年の間に市場で最も高いCAGRを記録すると予想されます。

流通チャネルに基づき、経皮ドラッグデリバリーシステム市場は病院薬局、小売薬局、オンライン薬局、その他に区分されます。病院薬局セグメントが2022年の市場で最大のシェアを占めています。しかし、小売薬局セグメントは2022-2030年の間に市場で最も高いCAGRを記録すると予想されています。

経皮ドラッグデリバリーシステム市場:地域別概要

2022年の経皮ドラッグデリバリーシステムの世界市場では、北米が最大のシェアを占めています。同地域では、米国が経皮ドラッグデリバリーシステム市場で最大のシェアを占めており、2022~2030年にかけて最も高いCAGRを記録すると予測されています。米国心臓協会(AHA)によると、心血管系疾患(CVD)は依然として米国の主要な死因です。CDCによると、2021年には、CVDは~695,000人の死亡を占め、米国の死亡の~5人に1人を占めています。心血管疾患、糖尿病、慢性疼痛状態、およびその他の慢性疾患の有病率の上昇は、効果的で便利な治療オプションに対する需要を促進しています。医療用パッチは、非侵襲的で患者に優しいアプローチを提供し、薬物を投与してこれらの慢性疾患に関連する症状を管理します。ウェアラブル・センサやフレキシブル・エレクトロニクスなど、TDDSの継続的な進歩が経皮ドラッグ・デリバリー・システム市場の成長に寄与しています。これらの進歩により、より正確な投与、患者モニタリングの強化、患者のコンプライアンス向上が可能になります。Biomaterials Research社が2021年に発行した「Recent advances in transdermal drug delivery systems(経皮ドラッグデリバリーシステムの最近の進歩)」と題する報告書によると、マイクロニードルはTDDSモダリティの中でも大きな注目を集めており、マイクロニードルの利点を組み合わせることで既存の単純な塗布タイプやパッチタイプのニードルの限界を克服し、より高い治療効率と効果を得ることができます。これらのTDDSの進歩は、心血管疾患や中枢神経系疾患、糖尿病、神経筋疾患、感染症や局所感染症などの蔓延を抑制する原動力となり得る。

個々の患者に合わせて治療を行う個別化医療の動向は、制御された標的ドラッグデリバリーを提供する医療用パッチの開発を後押ししています。このカスタマイズにより、患者の転帰が改善され、治療効果が向上します。例えば、2020年にはReddy's Laboratories社が米国市場でNitroDur(ニトログリセリン)経皮注入システムの正規ジェネリック・バージョンを発売しました。在宅ヘルスケアや患者の遠隔モニタリングが重視されるようになる中、医療用パッチは従来のヘルスケア環境以外でも薬剤を投与したりバイタルサインをモニタリングしたりできる便利なソリューションを提供します。米国の経皮ドラッグデリバリーシステム市場は、慢性疾患の有病率の増加、技術進歩の高まり、個別化医薬品への注目の高まりといった要因の影響を受けています。

経皮ドラッグデリバリーシステム市場に関するレポート作成時に参照した主な一次情報および二次情報には、世界銀行データ、国民保健サービス(NHS)、FDA(食品医薬品局)、EMA(欧州医薬品庁)、WHO(世界保健機関)などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 経皮ドラッグデリバリーシステム市場:地域別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 経皮ドラッグデリバリーシステム市場情勢

  • 世界のPEST分析

第5章 経皮ドラッグデリバリーシステム市場-主要産業力学

  • 市場促進要因
    • 慢性疾患の有病率の増加
    • 非侵襲ドラッグデリバリーデバイスへの需要の高まり
    • 薬剤の自己投与に対する高い需要
  • 市場抑制要因
    • 経皮ドラッグデリバリーシステムの副作用とリコール
  • 市場機会
    • スマートパッチと3Dプリントパッチの進歩
  • 今後の動向
    • メーカーによる戦略的取り組み
  • 影響分析

第6章 経皮ドラッグデリバリーシステム市場- 世界市場分析

  • 経皮ドラッグデリバリーシステム市場の収益、2022年~2030年

第7章 経皮ドラッグデリバリーシステム市場- 2030年までの収益と予測、製品別

  • 経皮ドラッグデリバリーシステム市場:2022年および2030年の収益シェア、製品別
  • 経皮吸収パッチ
  • 経皮ゲル
  • 経皮スプレー
  • その他

第8章 経皮ドラッグデリバリーシステムの世界市場:2030年までの収益と予測、用途別

  • 経皮ドラッグデリバリーシステム市場、収益シェア、2022年・2030年、用途別
  • 心血管疾患
  • 中枢神経系疾患
  • 疼痛管理
  • ホルモン用途
  • その他の用途

第9章 経皮ドラッグデリバリーシステムの世界市場:2030年までの収益と予測、流通チャネル別

  • 経皮ドラッグデリバリーシステム市場:2022年・2030年、収益シェア、流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第10章 経皮ドラッグデリバリーシステム市場:2030年までの収益と予測:地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第11章 経皮ドラッグデリバリーシステム市場の業界情勢

  • 経皮ドラッグデリバリーシステム市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • Purdue Pharma LP
  • UCB SA

第13章 付録

図表

List Of Tables

  • Table 1. Transdermal Drug Delivery System Market Segmentation
  • Table 2. North America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Germany Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. UK Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. UK Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. UK Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. UK Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. UK Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. UK Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Italy Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Italy Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Spain Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Spain Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Rest of Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Rest of Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. China Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. China Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Japan Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Japan Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. India Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. India Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Australia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Australia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South Korea Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. South Korea Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. South Korea Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. South Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. South Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Saudi Arabia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Saudi Arabia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Saudi Arabia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Saudi Arabia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. UAE Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. UAE Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. UAE Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. UAE Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. South & Central America: Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America: Transdermal Drug Delivery System Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. Brazil Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. Brazil Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Argentina Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Argentina Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Rest of South & Central America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Rest of South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 165. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 166. Glossary of Terms, Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Transdermal Drug Delivery System Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 4. Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 5. Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global Transdermal Drug Delivery System Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 27. Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. North America: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 32. North America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. North America: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 34. US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Europe: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 40. Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 49. China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 58. South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. South & Central America: Transdermal Drug Delivery System Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 63. South & Central America: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 64. South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
  • Figure 65. Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 66. Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 67. Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 68. Growth Strategies in the Transdermal Drug Delivery System Market
目次
Product Code: TIPRE00002894

The global transdermal drug delivery systems market is expected to reach US$ 51.949 billion in 2030 from US$ 37.230 billion in 2022. The market is estimated to grow with a CAGR of 4.3% from 2022 to 2030.

The key factors driving the market's growth include growing areas of application of transdermal drug delivery systems and rising cases of spinal cord injury. However, the post-surgical complications hinder the market growth.

Market Opportunities of Transdermal Drug Delivery Systems Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Factors Hampering Transdermal Drug Delivery Systems Market

Currently marketed transdermal drug delivery systems (TDDS), transmucosal drug delivery systems (TMDS), and topical patches may retain 10-95% of the initial total quantity of the drug as a residual drug after the intended use period. This raises a potential safety issue for patients, and their family members and caregivers. For example, adverse events due to a patient's failure to remove TDDS at the end of the intended use period generally result in an increased or prolonged pharmacological effect of the drug. Some children have also been reported to have died from accidental exposure to discarded TDDS. Below are some of the product recalls and withdrawals by the manufacturers.

In February 2023, Aveva Drug Delivery Systems Inc recalled two lots of buprenorphine transdermal systems for failing to meet impurity/degradation specifications. Aveva Drug Delivery Systems voluntarily initiated the recall on February 15, 2023, which was designated as a Class III recall by the FDA on March 14, 2023. Under this recall classification, the use of the product is not likely to cause any major harm. In September 2020, Teva Pharmaceuticals USA recalled two lots of buprenorphine patches. The recall affected 32,543 cartons of buprenorphine transdermal systems, 5 mcg/hour, four transdermal systems per carton (patch NDC 0093-3656-21, carton NDC 0093-3656-40), from lots 190017 and 190161. The product was manufactured by 3M Drug Delivery Systems for Teva Pharmaceuticals and distributed in the US and Puerto Rico. Followed by its voluntary recall by Teva Pharmaceuticals on September 4, 2020, the FDA designated the recall Class II on October 1, 2020. Continuing the use of Class II recall products may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm exists. Further, in April 2018, the FDA sent a Warning Letter to Phase 4 Pharmaceutical LLC. Instead of manufacturing transdermal drug types, the firm was functioning as a re-packager of over-the-counter (OTC) transdermal drug types, and the FDA found several violations of CGMP that affected the quality of its products. In April 2019, Alvogen, Inc. announced a voluntary, nationwide recall of two lots (or batches) of Fentanyl Transdermal System, 12 mcg/h transdermal patches, because of a label mix-up. Thus, adverse effects and recalls of transdermal drug delivery systems hinder the market growth.

Transdermal Drug Delivery Systems Market: Segmental Overview

Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022-2030. A transdermal patch is a drug delivery system attached to a patient's skin to deliver medication through the skin.

The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. Central nervous system disorders segment is expected to register the highest CAGR in the market during 2022-2030.

Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030.

Transdermal Drug Delivery Systems Market: Geographical Overview

North America accounted for the largest share of the global transdermal drug delivery systems market in 2022. In the region, the US held the largest transdermal drug delivery systems market share and is anticipated to register the highest CAGR during 2022-2030. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, enhanced patient monitoring, and improved patient compliance. According to a report titled "Recent advances in transdermal drug delivery systems," published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases.

The growing trend of personalized medicines, where treatments are tailored to individual patients, has boosted the development of medical patches that offer controlled and targeted drug delivery. This customization allows for better patient outcomes and improved therapeutic efficacy. For instance, in 2020, Reddy's Laboratories launched an authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market. With the growing emphasis on home healthcare and remote patient monitoring, medical patches offer a convenient solution for delivering medications and monitoring vital signs outside traditional healthcare settings. The US transdermal drug delivery system market is influenced by factors such as the increasing prevalence of chronic diseases, rising technological advancements, and growing focus on personalized medicines.

A few of the major primary and secondary sources referred to while preparing the report on the transdermal drug delivery systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the transdermal drug delivery systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global transdermal drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the transdermal drug delivery systems market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Transdermal Drug Delivery System Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 5.1.3 High Demand for Self-Administration of Drugs
  • 5.2 Market Restraints
    • 5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Manufacturers
  • 5.5 Impact Analysis

6. Transdermal Drug Delivery System Market - Global Market Analysis

  • 6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

7. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Transdermal Patches
    • 7.3.1 Overview
    • 7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Drug-in-Adhesive Patches
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.2 Matrix Patches
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.3 Reservoir Membrane Patches
        • 7.3.2.3.1 Overview
        • 7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.4 Vapor Patches
        • 7.3.2.4.1 Overview
        • 7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Transdermal Gels
    • 7.4.1 Overview
    • 7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Transdermal Sprays
    • 7.5.1 Overview
    • 7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Cardiovascular Diseases
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Central Nervous System Disorders
    • 8.4.1 Overview
    • 8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.1 Opioid
        • 8.5.2.1.1 Overview
        • 8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.2 Non-Opioid
        • 8.5.2.2.1 Overview
        • 8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hormonal Applications
    • 8.6.1 Overview
    • 8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 8.6.2.1.1 Overview
        • 8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.2 Testosterone Replacement
        • 8.6.2.2.1 Overview
        • 8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Other Application
    • 8.7.1 Overview
    • 8.7.2 Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

10. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 10.1 North America: Transdermal Drug Delivery System Market
    • 10.1.1 Overview
    • 10.1.2 North America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.1 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.3 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.2 Europe: Transdermal Drug Delivery System Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.2.6.1 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.3 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific: Transdermal Drug Delivery System Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.3.6.1 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.3 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Transdermal Drug Delivery System Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.1 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.3 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.5 South & Central America: Transdermal Drug Delivery System Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020-2030 (US$ Million)
      • 10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
      • 10.5.6.1 Brazil: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.1.1 Overview
      • 10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.3 Argentina: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.3.1 Overview
      • 10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.5.1 Overview
      • 10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Transdermal Drug Delivery System Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Novartis AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Johnson & Johnson
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 GSK Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Viatris Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Boehringer Ingelheim International GmbH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hisamitsu Pharmaceutical Co Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Luye Pharma Group Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lavipharm SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Purdue Pharma LP
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 UCB SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms